OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention
Pirashaanthy Tharmapalan, Mathepan Mahendralingam, Hal K. Berman, et al.
The EMBO Journal (2019) Vol. 38, Iss. 14
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells
Damiano Cosimo Rigiracciolo, Nijiro Nohata, Rosamaria Lappano, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 1010-1010
Open Access | Times Cited: 71

The role of R-spondin proteins in cancer biology
Eline J. ter Steege, Elvira R. M. Bakker
Oncogene (2021) Vol. 40, Iss. 47, pp. 6469-6478
Open Access | Times Cited: 66

Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling
Shengqi Wang, Jing Li, Shicui Hong, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 11

Dissecting tumor microenvironment from spatially resolved transcriptomics data by heterogeneous graph learning
Chunman Zuo, Junjie Xia, Luonan Chen
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9

Mechanism of action of genistein on breast cancer and differential effects of different age stages
Xiang Zhang, Bo Ma, Xin Pei, et al.
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 141-155
Open Access | Times Cited: 1

Breast cancer stem cell antigens as targets for immunotherapy
Elena Quaglino, Laura Conti, Federica Cavallo
Seminars in Immunology (2020) Vol. 47, pp. 101386-101386
Open Access | Times Cited: 65

A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer
Franklyn De Silva, Jane Alcorn
Cancers (2022) Vol. 14, Iss. 12, pp. 2954-2954
Open Access | Times Cited: 38

Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer
Ellen Langille, Khalid N. Al‐Zahrani, Zhibo Ma, et al.
Cancer Discovery (2022) Vol. 12, Iss. 12, pp. 2930-2953
Open Access | Times Cited: 34

Targeting Breast Cancer Stem Cells Using Naturally Occurring Phytoestrogens
Mai Nguyen, Clodia Osipo
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6813-6813
Open Access | Times Cited: 30

Progesterone from ovulatory menstrual cycles is an important cause of breast cancer
Herjan J.T. Coelingh Bennink, Iman J. Schultz, Marcus Schmidt, et al.
Breast Cancer Research (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 20

Midkine as a driver of age-related changes and increase in mammary tumorigenesis
Pengze Yan, Ernesto Rojas Jiménez, Zheqi Li, et al.
Cancer Cell (2024)
Open Access | Times Cited: 7

Mammary epithelial cells have lineage-rooted metabolic identities
Mathepan Mahendralingam, Hye‐Yeon Kim, Curtis W. McCloskey, et al.
Nature Metabolism (2021) Vol. 3, Iss. 5, pp. 665-681
Open Access | Times Cited: 38

Proteomics and its applications in breast cancer.
Anca-Narcisa Neagu, Danielle Whitham, Emma Buonanno, et al.
PubMed (2021) Vol. 11, Iss. 9, pp. 4006-4049
Closed Access | Times Cited: 38

Ferroptosis in cancer therapeutics: a materials chemistry perspective
Qun Guan, Lele Zhou, Yu‐Bin Dong
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 43, pp. 8906-8936
Closed Access | Times Cited: 37

Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Thomas E. Bartlett, Iona Evans, Allison Jones, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 25

Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis
Yue Yang, Yuanyuan Lu, Chunhua Zhang, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Closed Access | Times Cited: 24

Asymmetric cell division of mammary stem cells
Shaan N. Chhabra, Brian W. Booth
Cell Division (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 29

Ciliary signaling in stem cells in health and disease: Hedgehog pathway and beyond
Issei S. Shimada, Yoichi Kato
Seminars in Cell and Developmental Biology (2022) Vol. 129, pp. 115-125
Closed Access | Times Cited: 18

A positive TGF‐β/miR‐9 regulatory loop promotes the expansion and activity of tumour‐initiating cells in breast cancer
Yichen Liu, Ying Chen, Qiong Zhao, et al.
British Journal of Pharmacology (2023) Vol. 180, Iss. 17, pp. 2280-2297
Open Access | Times Cited: 10

Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures
James E. Barrett, Chiara Herzog, Sepideh Aminzadeh-Gohari, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top